ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2271

Variation of Interferon-Alpha Production in Healthy Individuals and Association with Autoimmune Susceptibility Genes

Olof Berggren1, Andrei Alexsson2, Gunnar V. Alm3, Ann-Christine Syvänen4, Lars Rönnblom2 and Maija-Leena Eloranta2, 1Department of Medical Sciences, SciLife Lab, Rheumatology, Uppsala University, Uppsala, Sweden, Uppsala, Sweden, 2Department of Medical Sciences, Section of Rheumatology, Uppsala University, Uppsala, Sweden, 3Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden, 4Department of Medical Sciences, Molecular Medicine, Uppsala University, Uppsala, Sweden

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: autoimmune diseases, Dendritic cells, genomics, Interferons and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Many autoimmune diseases, e.g. systemic lupus erythematosus (SLE), have an activated type I interferon (IFN) system and about 40 SLE susceptibility loci, many within the type I IFN pathway, have been identified. We recently showed that the IFNα production by plasmacytoid dendritic cells (pDC) is regulated by both NK and B cells, and demonstrated a large interindividual difference in IFNα producing capacity among healthy individuals. We therefore investigated whether the capacity to produce type I IFN correlates to single nucleotide polymorphisms (SNPs) associated with different autoimmune diseases.

Methods:

Plasmacytoid dendritic cells (pDC) (n = 130), B cells (n = 128) and NK (n = 66) were isolated from healthy blood donor PBMC genotyped with the 200K ImmunoChip (Illumina). PDC alone or in co-cultures with NK or B cells were stimulated with U1 snRNP- and SLE-IgG-containing immune complex (RNA-IC), herpes simplex virus or a synthetic oligonucleotide (ODN2216). The IFNα levels in the cell cultures were measured with an immunoassay after 20h. The association analysis was performed with PLINK software version 1.07. A total of 67 000 SNPs with minor allele frequency ≥20% which passed quality control were included in the analysis. The 10 most associated signals per cell type and stimuli were selected for further analysis. The IFNα production was normalized by Box-Cox transformation and the association to the genotype was analyzed by multiple linear regression with a stepwise method (SPSS 20.0).

Results:

The IFNα production by the stimulated healthy donor pDC alone or in cocultures with B or NK cells varied from <1 to 100000 U/ml. We found a strong association (p < 0.001) between the level of produced IFNα and several SNPs (24 to 194) depending on the combination of cell type and IFN inducer. The 7 most significant associations between IFNα production and specific SNPs among the 9 different combinations were located in C1orf222, MYO9B, TOX, between NFYAP1 and LGMNP1, and IL5RA genes (all p ≤ 0.00003).

Further analysis on the combined effect of the 10 most significant SNPs was applied on each different IFN inducer and cell type combination. For instance, the variation in IFNα production by pDC and B cells stimulated with RNA-IC could be explained to 59% by a model including SNPs located between ID4 and MBOAT1, in BLK, in MOBKL2B, in BICC1, between FAM86A and RBFOX1, and between IRF8 and FOXF1 (p < 1 x 10-18, r2 = 0.59).

Conclusion:

We found that the interindividual variation in IFNα production in healthy individuals upon stimulation with RNA containing IC as well as IFN inducers of microbial origin is associated to several autoimmune susceptibility genes. Our results may contribute to the identification of functional gene variants that directly affect the type I IFN production and IFN signature in patients with systemic autoimmune diseases. We envision that our approach using genetically characterized individuals can reveal crucial immunological targets for therapeutic intervention.


Disclosure:

O. Berggren,
None;

A. Alexsson,
None;

G. V. Alm,
None;

A. C. Syvänen,
None;

L. Rönnblom,
None;

M. L. Eloranta,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/variation-of-interferon-alpha-production-in-healthy-individuals-and-association-with-autoimmune-susceptibility-genes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology